Atas, N. Et Al. 2022. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis. CLINICAL RHEUMATOLOGY , vol.41, no.5 , 1381-1389.

Atas, N., Cakir, B., BAKIR, F., UÇAR, M., SATIŞ, H., Guz, G. T., ... DURMUŞ DEMİREL, K.(2022). The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis. CLINICAL RHEUMATOLOGY , vol.41, no.5, 1381-1389.

Atas, Nuh Et Al. "The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis," CLINICAL RHEUMATOLOGY , vol.41, no.5, 1381-1389, 2022

Atas, Nuh Et Al. "The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis." CLINICAL RHEUMATOLOGY , vol.41, no.5, pp.1381-1389, 2022

Atas, N. Et Al. (2022) . "The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis." CLINICAL RHEUMATOLOGY , vol.41, no.5, pp.1381-1389.

@article{article, author={Nuh Atas Et Al. }, title={The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis}, journal={CLINICAL RHEUMATOLOGY}, year=2022, pages={1381-1389} }